← Browse by Condition
Medical Condition
urinary bladder overactive
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for urinary bladder overactive sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 2
Top Sponsors
2 trials
1 trial
1 trial
Recruiting Clinical Trials
NCT05968885 Phase 4
Recruiting
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
Enrollment
300 pts
Location
Taiwan
Sponsor
Mackay Memorial Hospital
NCT06479720 Phase 4
Recruiting
Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder
Enrollment
300 pts
Location
Taiwan
Sponsor
Mackay Memorial Hospital
NCT06201013
Recruiting
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
Enrollment
180 pts
Location
China
Sponsor
Children's Hospital of Chongqi...
NCT07366918
Recruiting
Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder
Enrollment
63 pts
Location
Turkey (Türkiye)
Sponsor
Pamukkale University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology